ONCOassist oncology app has received the CE mark

398

ONCOassist (Portable Medical), a smartphone app that “allows oncologists to make complex decisions” has received the CE mark. The ONCOassist app is classed as a medical device and complies with EU regulations as a clinical decision support tool, according to the company website.

“A recent study in the Journal of Telemedicine and Telecare found no expert involvement in 86% of apps developed for pain management. We want to change this, we are in the process of developing a series of “assist” apps that will aid clinicians with their day-to-day decision making,” according to a statement on Portable Medical’s website.

ONCOassist was jointly developed by Eoin O’Carroll, Kevin Bambury and Richard Bambury all graduates of University College Cork, Ireland.

(Visited 25 times, 1 visits today)